- Forge Biologics, a cGMP manufacturing and development company, announced today that Timothy J. Miller , Ph.D., Chief Executive Officer, President, and Co-Founder will present at the annual Cell & Gene Meeting on the Mediterranean, which will be held virtually April 6-9, 2021 .
| COLUMBUS, Ohio, April 6, 2021 /PRNewswire/ -- Forge Biologics, a cGMP manufacturing and development company, announced today that Timothy J. Miller, Ph.D., Chief Executive Officer, President, and Co-Founder will present at the annual Cell & Gene Meeting on the Mediterranean, which will be held virtually April 6-9, 2021. Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mediterranean is a four-day virtual conference featuring more than 80 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies. “I’m honored to be presenting alongside a lineup of industry leaders and to share the groundbreaking progress that Forge Biologics has made in less than 9 months since closing our Series A in July 2020,” said Dr. Miller. Forge Biologics’ company presentation will be available to view on-demand throughout the entirety of the conference. Attend the conference at www.meetingonthemed.com. About Forge Biologics For more information, please visit www.forgebiologics.com. Media Inquiries: Business Development Investor Relations Patient, Pediatrician, Genetic Counselors & Family Inquiries
SOURCE Forge Biologics |
View original content to download multimedia:
